Arcutis Biotherapeutics, Inc. - Common stock (NQ: ARQT )
13.21
+1.81
(+15.88%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 12, 2025
Add to My Watchlist
Press Releases about Arcutis Biotherapeutics, Inc. - Common stock![]() ![]() ![]()
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
November 13, 2024
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|